Functional mapping of drug response with pharmacodynamic-pharmacokinetic principles

被引:20
作者
Ahn, Kwangmi [2 ]
Luo, Jiangtao [2 ]
Berg, Arthur [2 ]
Keefe, David [1 ]
Wu, Rongling [2 ]
机构
[1] NYU, Dept Obstet & Gynecol, Langone Med Ctr, New York, NY 10016 USA
[2] Penn State Univ, Ctr Stat Genet, Hershey, PA 17033 USA
关键词
DYNAMICS IN-VIVO; HIV-1; DYNAMICS; CIRCADIAN-RHYTHMS; STATISTICAL-MODEL; SYSTEMS BIOLOGY; PHARMACOGENOMICS; GENETICS; METABOLISM; MEDICINE; THERAPY;
D O I
10.1016/j.tips.2010.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent research in pharmacogenomics has inspired our hope to predict drug response by linking it with DNA information extracted from the human genome. However, many genetic models of drug response do not incorporate biochemical principles of host-drug interactions, limiting the effectiveness of the predictive models. We argue that functional mapping, a computational tool aimed at identifying genes and genetic networks that control dynamic traits, can help explain the detailed genetic architecture of drug response by incorporating pharmacokinetic and pharmacodynamic processes. Functional mapping is particularly powerful in determining the genetic commonality and differences of drug efficacy vs. drug toxicity and drug sensitivity vs. drug resistance. We pinpoint several future directions in which functional mapping can be coupled with systems biology to unravel the genetic and metabolic machinery of drug response.
引用
收藏
页码:306 / 311
页数:6
相关论文
共 45 条
[1]   Genetic Mapping in Human Disease [J].
Altshuler, David ;
Daly, Mark J. ;
Lander, Eric S. .
SCIENCE, 2008, 322 (5903) :881-888
[2]  
Bellouquid A., 2006, MATH MODELING COMPLE
[3]   Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance [J].
Clairambault, Jean .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (9-10) :1054-1068
[4]   Pharmacogenetics and geographical ancestry: implications for drug development and global health [J].
Daar, AS ;
Singer, PA .
NATURE REVIEWS GENETICS, 2005, 6 (03) :241-246
[5]   Personalizing medicine: a systems biology perspective [J].
Deisboeck, Thomas S. .
MOLECULAR SYSTEMS BIOLOGY, 2009, 5
[6]   Visualizing gene determinants of disease in drug discovery [J].
Delrieu, O ;
Bowman, C .
PHARMACOGENOMICS, 2006, 7 (03) :311-329
[7]   Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: Concepts and perspectives [J].
Derendorf, H ;
Meibohm, B .
PHARMACEUTICAL RESEARCH, 1999, 16 (02) :176-185
[8]   Molecular bases for circadian clocks [J].
Dunlap, JC .
CELL, 1999, 96 (02) :271-290
[9]   Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J].
Evans, WE ;
McLeod, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :538-549
[10]   Pharmacogenomics: The inherited basis for interindividual differences in drug response [J].
Evans, WE ;
Johnson, JA .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2001, 2 :9-39